Edition:
India

Pfizer Inc (PFE.N)

PFE.N on New York Stock Exchange

37.60USD
11:25pm IST
Change (% chg)

$-0.05 (-0.12%)
Prev Close
$37.65
Open
$37.58
Day's High
$37.73
Day's Low
$37.49
Volume
1,636,399
Avg. Vol
7,113,055
52-wk High
$39.43
52-wk Low
$32.33

Chart for

About

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines, as well as consumer healthcare products. The Company manages its commercial operations through two business... (more)

Overall

Beta: 0.99
Market Cap(Mil.): $214,682.30
Shares Outstanding(Mil.): 5,955.13
Dividend: 0.32
Yield (%): 3.55

Financials

  PFE.N Industry Sector
P/E (TTM): 26.26 30.93 32.76
EPS (TTM): 1.37 -- --
ROI: 6.00 15.07 14.61
ROE: 13.80 16.60 16.34

Pfizer-Lilly pain drug meets late-stage trial goals

An experimental osteoarthritis drug developed by Pfizer Inc and Eli Lilly and Co achieved its main goal of lowering pain in a late stage trial, the companies said on Wednesday, potentially offering a safer alternative to opioids.

6:21pm IST

Pfizer-Lilly pain drug meets late-stage trial goals

An experimental osteoarthritis drug developed by Pfizer Inc and Eli Lilly and Co achieved its main goal of lowering pain in a late stage trial, the companies said on Wednesday, potentially offering a safer alternative to opioids.

6:21pm IST

UPDATE 2-Pfizer-Lilly pain drug meets late-stage trial goals

July 18 An experimental osteoarthritis drug developed by Pfizer Inc and Eli Lilly and Co achieved its main goal of lowering pain in a late stage trial, the companies said on Wednesday, potentially offering a safer alternative to opioids.

6:19pm IST

Pfizer-Lilly pain drug found effective in late-stage study

July 18 An experimental drug developed by Pfizer Inc and Eli Lilly and Co achieved its main goal of reducing pain in osteoarthritis patients in a late stage trial, the companies said on Wednesday.

4:27pm IST

Pfizer separates consumer health unit in business rejig

Pfizer Inc announced plans on Wednesday to reorganize into three units, separating its consumer healthcare business that the U.S. drugmaker has been trying to sell since last year. | Video

12 Jul 2018

Pfizer to split into three units, separates consumer healthcare

Pfizer Inc said on Wednesday it would reorganize into three units, separating its consumer healthcare business that the U.S. drugmaker has been trying to sell since last year. | Video

12 Jul 2018

Deals of the day-Mergers and acquisitions

July 11 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:

12 Jul 2018

Trump told Pfizer CEO price hikes hurt his drug plan: source

NEW YORK/WASHINGTON U.S. President Donald Trump called Pfizer Chief Executive Ian Read on Tuesday to say the company's July 1 price hikes had complicated the administration's drug pricing plans, prompting the company to defer its planned increases, according to a source familiar with the matter.

12 Jul 2018

Trump told Pfizer CEO price hikes hurt his drug plan: source

NEW YORK/WASHINGTON U.S. President Donald Trump called Pfizer Chief Executive Ian Read on Tuesday to say the company's July 1 price hikes had complicated the administration's drug pricing plans, prompting the company to defer its planned increases, according to a source familiar with the matter.

12 Jul 2018

UPDATE 3-Trump told Pfizer CEO price hikes hurt his drug plan -source

NEW YORK/WASHINGTON, July 11 U.S. President Donald Trump called Pfizer Chief Executive Ian Read on Tuesday to say the company's July 1 price hikes had complicated the administration's drug pricing plans, prompting the company to defer its planned increases, according to a source familiar with the matter.

12 Jul 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $127.52 -1.59
Novartis AG (NOVN.S) CHF80.66 +2.46
Merck & Co., Inc. (MRK.N) $62.88 +0.35
Roche Holding Ltd. (ROG.S) CHF234.75 +2.75
Roche Holding Ltd. (RO.S) CHF238.80 +2.00
Abbott Laboratories (ABT.N) $64.48 +1.68
Bayer AG (BAYGn.DE) €92.96 -0.45
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €72.51 +0.67
AstraZeneca plc (AZN.L) 5,606.00 +55.00

Earnings vs. Estimates